SCHEMBL23309595

SCHEMBL23309595

O=C(Nc1cccc(Cl)c1Cl)c1cc(F)nc(F)c1F

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ EPHB3 P54753 1/20 0.47
▸ MEN1 O00255 7/20 0.47
▸ KMT2A Q03164 7/20 0.47
▸ GAA P10253 1/20 0.46
▸ LMNA P02545 4/20 0.46
▸ MAPT P10636 3/20 0.46
▸ HPGD P15428 2/20 0.46
▸ NPC1 O15118 1/20 0.46
▸ RAB9A P51151 1/20 0.46
▸ SMN1; SMN2 Q16637 1/20 0.46
▸ POLB P06746 1/20 0.45
▸ HTT P42858 1/20 0.44
▸ KDM4E B2RXH2 2/20 0.43
▸ XBP1 P17861 1/20 0.43
▸ CYP1A2 P05177 2/20 0.43
▸ CYP2C19 P33261 2/20 0.43
▸ ALDH1A1 P00352 2/20 0.43
▸ TP53 P04637 1/20 0.43
▸ RXFP1 Q9HBX9 1/20 0.43
▸ KDR P35968 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23309603 0.89 CYP1A2 (0.56) EPHB3MEN1KMT2AHPGDNPC1
SCHEMBL23309697 0.78 HTT (0.56) MEN1KMT2AGAALMNAMAPT
SCHEMBL23309546 0.78 NFKB1 (0.50) KMT2AMAPTNPC1RAB9AKDM4E
SCHEMBL23309548 0.77 FADS1 (0.55) MEN1KMT2AGAALMNAMAPT
SCHEMBL23309730 0.75 KMT2A (0.47) MEN1KMT2AGAALMNAMAPT
SCHEMBL23309708 0.75 RAB9A (0.52) KMT2AGAALMNANPC1RAB9A
SCHEMBL23309495 0.75 FADS1 (0.56) MEN1KMT2ALMNAMAPTNPC1
SCHEMBL23309490 0.75 GAA (0.51) MEN1KMT2AGAALMNAHPGD
SCHEMBL23309502 0.75 NFKB1 (0.51) MEN1KMT2AMAPTHPGDNPC1
SCHEMBL23309594 0.74 POLB (0.50) KMT2ANPC1POLBKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210120817-A1 PLANT DISEASE CONTROL AGENT MEIJI SEIKA PHARMA CO., LTD. (JP) 2021-04-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210120817-A1 PLANT DISEASE CONTROL AGENT BROX, ALG1, CTRL EPHB3 4222/4885MEN1 1633/4885KMT2A 2360/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback